Immunogenicity and Reactogenicity of the Booster Dose of COVID-19 Vaccines and Related Factors: A Panel Study from the General Population in Serbia

The Republic of Serbia applied the booster dose of the following COVID-19 vaccines: BNT162b2 mRNA (Pfizer-BioNTech), Sinopharm BBIBP-CorV (Vero Cell(®)), Gam-COVID-Vac (Sputnik V) and ChAdOk1 nCoV-19 (AstraZeneca). We aimed to examine the immunogenicity and reactogenicity of the booster dose and ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Stosic, Maja, Milic, Marija, Markovic, Milos, Kelic, Ivana, Bukumiric, Zoran, Veljkovic, Marko, Kisic Tepavcevic, Darija, Saponjic, Vladan, Plavsa, Dragana, Jovanovic, Sofija, Jovanovic, Verica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228276/
https://www.ncbi.nlm.nih.gov/pubmed/35746446
http://dx.doi.org/10.3390/vaccines10060838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228276/
https://www.ncbi.nlm.nih.gov/pubmed/35746446
http://dx.doi.org/10.3390/vaccines10060838

Ejemplares similares